Biotech: Page 38
-
PharmaVoice Team/PharmaVoice
Vested Outsourcing Imperative
Managing the Talent Supply Chain Large life sciences companies today face many challenges in acquiring and managing talent to meet their business imperatives. The first decision to be made is always the same, whether the workforce contains full-time employees, contingent workers, independent cont...
By Kevin D. Duffy • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Supply Chain: Talent Management: A Different Supply Chain Issue
A sound workforce strategy furthers a company’s business agenda and generates results. When the topic of supply chain management is discussed, the conversation typically is about manufacturing and distribution issues. But today one of the most pressing challenges facing CEOs is the talent supply ...
By Taren Grom • Sept. 27, 2014 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Colombia Emerges as an Attractive Pharma Market
With a growing interest in attracting R&D and continual economic growth, Colombia is seen as an attractive market for pharmaceutical companies. The Republic of Colombia is evolving from an emerging economy, having enjoyed an economic turnaround since 2000, when it was perceived by economists ...
By Kim Ribbink • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Education of Principal Investigators
Efforts by pharma companies and other organizations aim to standardize GCP and training requirements for clinical research investigators and sites. Principal investigators and clinical sites are the backbone of clinical research. Sponsors and CROs depend on investigators and sites to conduct stud...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
New Models for Academic Partnerships
Academic medical centers have a renewed interest in partnering with pharmaceutical companies and are investing resources to ensure successful collaborations. Industry partnerships with universities are changing. These collaborations are no longer about single projects. They are broader in scope, ...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Nanomedicine Revolution
Nanomedicines have the potential to improve effectiveness and reduce the side effects of therapeutics. Nanotechnology has the potential to revolutionize healthcare across disciplines and specialties. For medicines specifically, nanotechnology can improve drug targeting and effectiveness and reduc...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
In the Pharmacy
As pharmacists’ roles expand to near provider status, new opportunities for partnerships open up for pharma. Over the years, pharmacists’ duties have been expanding, but recent legislative acts and regulations are providing the stimulus for an even more robust role. Pharmacists are becoming full ...
By Robin Robinson • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Last Word
The HBA Turns 35 Laurie Cooke, CEO of the Healthcare Businesswomen’s Association (HBA), discusses the organization’s strategic mission for the future as it celebrates its 35th anniversary. PV: The HBA was originally conceptualized 37 years ago by five women and became an official nonprofit orga...
By Laurie Cooke • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Rise of Biosimilars
The promise of biosimilars is to provide cost-savings, increased patient access, and promote innovation. The biotechnology market in the United States is about to be altered significantly. In July, Sandoz announced it was the first company to file an application under the biosimilars pathway crea...
By Denise Myshko • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Last Word
Collaborating for a Cure Walter Capone, President of the Multiple Myeloma Research Foundation, talks about data sharing, open access to research, and how collaborative research can lead to new therapies. PV: How did the open access data portal, the MMRF Researcher Gateway, get started? CAPONE: T...
By Walter Capone • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool DR. JOHN ORLOFF Baxter Appoints VP of BioScience R&D Baxter International has appointed John Orloff, M.D., as VP and global head of research and development for Baxter BioScience. Dr. Orloff joins Baxter from Merck Serono Pharmaceuticals, where he served as global head of clinical...
By Ann Grey • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Social Buzz
A collection of social media news, events, and strategies. Trending now: Mobile technology improves patient outcomes. A randomized control trial conducted through the Montefiore Medical Center earlier this year found a significant improvement in a number of key patient engagement metrics when car...
By Taren Grom • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A Single Pill for Multiple Viruses The treatment of viral infections is an unmet medical need. While many viruses such as rhinoviruses, which cause the cold, are not considered serious, others, such as ebola, are. There are more than 200 viruses that cause mild-to-severe diseases that have limite...
By Lillian Chiang • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 - Who's on the List by Section
These extraordinary leaders, representing a wide range of industry sectors and functional areas of expertise, are having a positive impact on their colleagues, their companies, and the greater healthcare community. See who you know! Who’s on the List — 2014 Indexed by Section The Academics Dr. Mo...
By Taren Grom • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Veeva Systems Introduces Commercial Cloud for Life Sciences Trending Now: New industry cloud brings together master data, compliant content, and customer interactions across all channels to transform commercial operations. Veeva Systems has unveiled Commercial Cloud, a next-generation solution to...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
What's New
Global Outcomes Group Launches to Support Outcomes Research Trending Now: New full-service medical communications agency focuses on supporting growing health economics and outcomes research in biopharma industry. The Global Outcomes Group has been formed to support the content and communication n...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
2014 PharmaVOICE 100 - Who's on the List by Company
Who’s on the List — 2014 Indexed by Company Affiliation AbelsonTaylor – Dr. Jeffrey Berg Advanced Clinical LLC – Susan Seroskie Advanced Clinical LLC – Julie Ross Baxter Healthcare Corp. – John Glasspool BBK Worldwide – Aaron Fleishman BioClinica Inc. – Dr. Boaz Mendzelevski Biogen Idec – Dr. Kat...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Kowa and Football Player Help those with High Cholesterol Kowa Pharmaceuticals America has announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife Brenda, to launch First and Goal, a national education initiative to help people prioritize h...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The 2014 PharmaVOICE 100 The PharmaVOICE 100 Turns 10! It’s hard to believe that 10 years after the vision for this issue was captured on the back of a napkin during a long flight delay, we have now profiled 1,000 of the industry’s most inspirational and motivational individuals making this issue...
By Taren Grom • July 28, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Clinical Trial Solutions: The Upside of Clinical Solutions
Even as pharmaceutical companies and their development partners continue to grapple with bringing safe products to market on time and on budget, new technologies, models, and analytics are driving improvements to counter the industry’s challenges. According to R&D leaders who recently partici...
By PharmaVoice Team • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Thailand Makes Great Strides in Healthcare
With a growing pharmaceutical market, renowned biotechnology research programs, and strong government support for the industry, Thailand has much to recommend it to the global pharma industry. The Kingdom of Thailand, a country with a population of 70 million people, is regarded as newly industri...
By Kim Ribbink • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool executive appointments and promotions in the healthcare industry Pharma Pool DR. UDIT BATRA EMD Millipore Introduces CEO and President EMD Millipore, the life-sciences division of Merck KGaA, has appointed Udit Batra, Ph.D., as president and CEO, responsible for the organization’s str...
By Ann Grey • May 29, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including Special Discounts Coming Attractions This year marks the 50th Anniversary of the DIA Annual Meeting, the largest multidisciplinary event that brings together a global network of life-sciences professionals to foster innovation that will lead...
By Heather Hummel • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Malaysia Focuses on Growth with Healthcare a Top Priority
Malaysia presents an attractive market to pharmaceutical companies thanks to growing government support, good infrastructure, and a trusted manufacturing environment. Malaysia is a federal constitutional monarchy with a population of about 29 million and an open and growing economy. According to ...
By Kim Ribbink • April 28, 2014 -
PharmaVoice Team/PharmaVoice
HBA's 2014 Rising Stars
Joyce Acbay Senior Director, Regulatory Affairs Actelion Pharmaceuticals Joyce is passionate about mentoring women and helping others reach their professional goals. Lorrie Albinson Associate Director, Sales Training and Development Actavis Brand Sales Actavis Lorrie is a distinguished leader at ...
By Taren Grom • April 28, 2014
Previous
